Rating History for Amneal Pharmaceuticals (AMRX) by Goldman Sachs

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/6/2025 Matt Dellatorre New Coverage Neutral
(N/A)
12.00
(N/A)
7.21
(13.24)
83.63% Details